The FastPack IP Sex Hormone Binding Globulin Immunoassay, Part #25000081, is for the quantitative...

FDA Device Recall #Z-0805-2025 — Class III — December 3, 2024

Recall Summary

Recall Number Z-0805-2025
Classification Class III — Low risk
Date Initiated December 3, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Qualigen Inc
Location Carlsbad, CA
Product Type Devices
Quantity 426

Product Description

The FastPack IP Sex Hormone Binding Globulin Immunoassay, Part #25000081, is for the quantitative measurement of SHBG in human serum and plasma. For in vitro diagnostic Use and contains 30 FastPacks.

Reason for Recall

Three lots of the FastPacks kitted into the FastPack SHBG Complete Kits were labeled with the incorrect expiration date. The following is a listing of affected lots: Lot Number: 2408018-1, 2409015-1, and 2409015-2. The likelihood of patient harm is expected to be low as routine Quality Control should detect kits that are impacted by signal deterioration due to age.

Distribution Pattern

Distribution was made to AR, CA, CO, FL, IL, IN, MA, MO, NC, NY, OH, OK, TN, TX, and VA. There was no military/government/foreign distribution.

Lot / Code Information

UDI-DI: 20816467020345, Lot numbers: 2408018-1 Exp: 2025-09-05; 2409015-1, Exp: 2025-06-27; and 2409015-2, Exp: 2025-06-26.

Other Recalls from Qualigen Inc

Recall # Classification Product Date
Z-0022-2025 Class II FastPack TSH Calibrator Kit, REF: 25000024, For... Aug 26, 2024
Z-1672-2020 Class II The FastPack System Comlete Immunoassay Kit ... Nov 6, 2019
Z-3112-2017 Class II Qualigen(R) The FastPack(R) IP Vitamin D Comple... Jul 7, 2017
Z-0550-2014 Class II FastPack Free T4 Immunoassay FastPack Vitamin... Nov 8, 2013
Z-0548-2014 Class II FastPack Testosterone Immunoassay Chemilunesc... Nov 8, 2013

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.